Health Dictionary Find a Doctor

Prolactinoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Anmol Pitliya, M.B.B.S. M.D.[3]

Overview

Surgery is not the first-line treatment option for patients with prolactinoma. Surgery is usually reserved for patients in whom medical therapy fails to reduce the size of the tumor.

Surgery

Indications

Medical therapy should be continued even if it is partially successful, possibly combined with surgery or radiation. Surgery is indicated in patients if medical therapy:[1][2][3]

Transsphenoidal resection

Transsphenoidal approach to pituitary tumor – Source: Wikimedia.org[4]
_fioC34LZeg|500}}

Endoscopic transsphenoidal surgery[5]

  • In this method, the pituitary tumor is excised through nostrils by means of a tiny fiber-optic endoscopic tube.
  • First, bilateral nasal septal mucosa is incised in a C-shaped manner. The septal bone is approached through this incision.
  • Then, sphenoidal rostrum and anterior wall of sphenoid sinus are gradually removed, a bone window is opened through the skull space.
  • After that, the dura mater is passed and the lesion becomes visible.
  • Finally, the tumor is removed using curette and basket with suction.
  • Advantages:
    • No harm to other parts of the brain
    • High cure rate
    • No visible scar
  • Disadvantages:

Craniotomy[6]

  • Although the preferred procedure to excise the pituitary tumors is a trans-sphenoidal approach, but in some cases (1-4%) the size of the tumor or any suprasellar adhesion may require trans-cranial method.
  • Situations requiring transcranial method include:
  • Skull base surgical procedure is also the option for pituitary tumor treatment but may encounter the problems that transsphenoidal method is faced with.
  • Advantages:
    • Resection of large tumors
    • Ability to excise the tumors with suprasellar specific conditions
  • Disadvantages:
    • Long duration of post-operation recovery
    • Damage to other parts of the brain

References

  1. “Prolactinoma | NIDDK”.
  2. Colao A, Savastano S (2011). “Medical treatment of prolactinomas”. Nat Rev Endocrinol. 7 (5): 267–78. doi:10.1038/nrendo.2011.37. PMID 21423245.
  3. Nomikos P, Buchfelder M, Fahlbusch R (2001). “Current management of prolactinomas”. J Neurooncol. 54 (2): 139–50. PMID 11761431.
  4. BruceBlaus-Own work, <“https://commons.wikimedia.org/w/index.php?curid=61131794“> Invalid parameter “puberty” in <ref> tag. The supported parameters are: dir, follow, group, name.
  5. Fan YP, Lv MH, Feng SY, Fan X, Hong HY, Wen WP; et al. (2014). “Full Endoscopic Transsphenoidal Surgery for Pituitary Adenoma-emphasized on Surgical Skill of Otolaryngologist”. Indian J Otolaryngol Head Neck Surg. 66 (Suppl 1): 334–40. doi:10.1007/s12070-011-0317-4. PMC 3918297. PMID 24533411.
  6. Youssef AS, Agazzi S, van Loveren HR (2005). “Transcranial surgery for pituitary adenomas”. Neurosurgery. 57 (1 Suppl): 168–75, discussion 168–75. PMID 15987585.


Template:WikiDoc Sources

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH